Cargando…

RF34 | PMON202 The Human Metabolic Profile of Estetrol

OBJECTIVES: Estetrol (E4), a native estrogen produced by the fetal human liver, has four hydroxyl-groups, making it structurally distinct from other estrogens. We determined the human metabolic profile of E4, which is recently marketed combined with drospirenone as a novel contraceptive and is curre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gérard, Céline, Apter, Dan, Chatel, Guillaume, Nollevaux, Fabrice, Jost, Maud, Gaspard, Ulysse, Foidart, Jean-Michel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Reproductive Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625469/ http://dx.doi.org/10.1210/jendso/bvac150.1472

Ejemplares similares

An Oral Contraceptive Containing Estetrol 15 MG and Drospirenone 3 MG Has Limited Effects on Endocrine and Metabolic Parameters
por: Klipping, Christine, et al.
Publicado: (2021)

The Effect of Estetrol/Drospirenone on Ovarian Function Is Similar to a Well-Established Combined Oral Contraceptive: Results From a Phase 2 Study
por: Duijkers, Ingrid J M, et al.
Publicado: (2021)

Low Thrombin Generation in Users of a Contraceptive Containing Estetrol and Drospirenone
por: Morimont, Laure, et al.
Publicado: (2022)

RF34 | PMON222 Reproductive Hormone Secretion is Increased by Intranasal Kisspeptin in Humans
por: Mills, Edouard G, et al.
Publicado: (2022)

RF34 | PMON229 TNFa-Induced Altered miRNA Expression Links to Inflammation in Endometriosis
por: Chowdhury, Indrajit, et al.
Publicado: (2022)

The benefits of estetrol addition to drospirenone for contraception
por: Foidart, Jean Michel, et al.
Publicado: (2023)

RF34 | PMON254 Why Does Androgens Fail to Promote the Survival of the Wolffian Duct in the Absence of Wnt9b?
por: Crossen, McKenna, et al.
Publicado: (2022)

RF34 | PMON203 Copy Number Variant Analysis Reveals Novel Candidate Genes Associated with Primary Ovarian Insufficiency
por: Franca, Monica, et al.
Publicado: (2022)

RF10 | PMON221 11-Oxygenated-Androgens in Females with Severe Insulin Resistance
por: Merke, Deborah, et al.
Publicado: (2022)

RF34 | PMON276 The Effect of Gender Affirming Hormone Therapy (GAHT) on Non-Conventional Cardiovascular Risk Markers in Transgender Men: A Systematic Review
por: Moreira Allgayer, Roberta Martins Costa, et al.
Publicado: (2022)

Response to paper by Binkowska et al. Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings. Commentary: Oestradiol is not the holy grail in the quest for the ideal oestrogen therapy
por: Douxfils, Jonathan, et al.
Publicado: (2023)

RF34 | PMON263 Study of Testosterone Replacement in Hypogonadal Men With Uncontrolled Type 2 Diabetes – a Randomised Double Blinded Placebo Controlled Trial (STRIDE Study)
por: Mohan Rao, Preethi, et al.
Publicado: (2022)

FRI378 Estetrol Prolongs Anagen In Healthy Female Scalp Hair Follicles By Positively Modulating Dermal Papilla Functions And Generation Of Progenitor Stem Cells Ex Vivo
por: Gerard, Celine, et al.
Publicado: (2023)

RF10 | PMON218 Direct Costs of Mental Health Disorders in PCOS: Systematic Review and Meta-Analysis
por: Bonner, Adam, et al.
Publicado: (2022)

RF10 | PMON216 Aromatase Inhibition Fails to Exaggerate Weight Gain and Induce Bone Loss in Ovariectomized Female Marmosets
por: Willging, Molly, et al.
Publicado: (2022)

RF10 | PMON241 Temporal Changes in Phenotype and Gut microbiota in PCOS Mouse Model Induced by Prenatal Androgen Exposure.
por: Kusamoto, Akari, et al.
Publicado: (2022)

Estetrol: From Preclinical to Clinical Pharmacology and Advances in the Understanding of the Molecular Mechanism of Action
por: Gérard, Céline, et al.
Publicado: (2023)

A multicenter, randomized, placebo-controlled study to select the minimum effective dose of estetrol in postmenopausal participants (E4Relief): part 2—vaginal cytology, genitourinary syndrome of menopause, and health-related quality of life
por: Gaspard, Ulysse, et al.
Publicado: (2023)

RF10 | PMON217 Replication of PCOS Reproductive and Metabolic Subtypes in Diverse Cohorts – Towards a Rationale Approach to PCOS Classification
por: Dapas, Matthew, et al.
Publicado: (2022)

A multicenter, randomized study to select the minimum effective dose of estetrol (E4) in postmenopausal women (E4Relief): part 1. Vasomotor symptoms and overall safety
por: Gaspard, Ulysse, et al.
Publicado: (2020)

RF10 | PMON204 Eucaloric High Fat Diet Does Not induce insulin Resistance But May Stimulate Fat Oxidation in Normal Weight Women
por: Schauer, Irene, et al.
Publicado: (2022)

RF02 | PMON309 Two Siblings with p.Arg92Trp Variant in NR5A1 Presenting with Testicular Disorder of Sexual Differentiation
por: Abisad, Daniela Aguilar, et al.
Publicado: (2022)

PMON260 Cost-Effectiveness of Testosterone Treatment for Men with Hypogonadism
por: Jayasena, Channa, et al.
Publicado: (2022)

PMON275 GONAD-on-CHIP to study early gonad development and DSD
por: Bashamboo, Anu, et al.
Publicado: (2022)

PMON209 Ceramides Predict Metabolic Response to Metformin in Women with PCOS
por: Sharma, Anu, et al.
Publicado: (2022)

RF10 | PMON215 Greater changes in metabolic hormones are associated with a smaller decrease in pulsatile LH secretion in response to short term moderate energy restriction in healthy, young women
por: Shekhar, Skand, et al.
Publicado: (2022)

RF10 | PMON249 MicroRNA-21 Ablation Exacerbates Androgen-Mediated White Adipose Tissue Dysfunction and Impaired Insulin Signaling in a Mouse Model of Polycystic Ovary Syndrome
por: Rezq, Samar, et al.
Publicado: (2022)

PMON223 Sellar Meningioma in Association with Fertility Treatment, A Case Report
por: Alnahas, Zeinab, et al.
Publicado: (2022)

PMON226 Primary Ovarian Insufficiency: A Case of a Missed Puberty
por: Lin, Jack, et al.
Publicado: (2022)

RF10 | PMON242 Free Testosterone is an Independent Predictor of Metabolic Syndrome Severity in U.S. Adolescent Girls Ages 12-19, National Health and Nutrition Examination Survey (NHANES) 2013-2016
por: McCartney, Christopher, et al.
Publicado: (2022)

PMON278 Research Priorities of Gender Diverse Adults: What is Most Important to the Community?
por: Kline, Danielle M, et al.
Publicado: (2022)

PMON246 Prevalence of Hypertension and Metabolic Syndrome in Women with PCOS from France and Brazil
por: Spritzer, Poli Mara, et al.
Publicado: (2022)

PMON201 The Impact of Menopause on Poor Outcomes in Hospitalized Patients with COVID-19 Infection
por: Toure, Tonslyn, et al.
Publicado: (2022)

PMON228 The Hidden Source of Testosterone Hypersecretion in a Female - a Thirty-Year Journey
por: Yang, Almira, et al.
Publicado: (2022)

Estetrol and Mammary Gland: Friends or Foes?
por: Gallez, Anne, et al.
Publicado: (2021)

PMON257 Oral Ingestion of Macronutrients Selectively and Variably Decrease Circulating Testosterone Concentration in Healthy Men
por: Iranmanesh, Ali, et al.
Publicado: (2022)

PMON214 Kisspeptin Restores Sexual and Attraction Brain Processing in Women with Hypoactive Sexual Desire Disorder
por: Thurston, Layla, et al.
Publicado: (2022)

PMON208 METFORMIN, SPIRONOLACTONE AND ORAL CONTRACEPTIVES IN POLYCYSTIC OVARY SYNDROME: A NETWORK META-ANALYSIS
por: Rodriguez-Gutierrez, Rene, et al.
Publicado: (2022)

PMON227 Rare ovarian luteinized fibrothecoma as cause of severe hyperandrogenism in a pre-menopausal woman.
por: Mikkilineni, Pushyami, et al.
Publicado: (2022)

PMON281 PERSISTENT VIRILIZATION AND VASOMOTOR SYMPTOMS IN A TRANSMAN 5-YEARS POST TESTOSTERONE WITHDRAWAL
por: Nemati, Maryam, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pu8t5a5us8o1er555ma4ukfibr